Showing results (201-210 of 2,196) with videos related to
Sort By:
Pageof 220
Clinical Pediatrics|February 1, 1991
Early identification of hearing loss: listen to parentsM D Thompson, G ThompsonClinical Pharmacology and Therapeutics|December 23, 2006
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokineticsN F Smith, S Marsh, T J Scott-Horton, et al.Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.Blood|September 15, 1994
Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II studyF M Foss, T A Borkowski, M Gilliom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulationsE C Kohn, W D Figg, G A Sarosy, et al.Seminars in Oncology|October 31, 2001
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancerW D Figg, P Arlen, J Gulley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transductionW D Figg, K A Cole, E Reed, et al.International Journal of Oncology|February 20, 1999
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivoS W Melchior, L G Brown, W D Figg, et al.Blood|June 15, 1995
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I studyE A Sausville, D Headlee, M Stetler-Stevenson, et al.The Journal of Surgical Research|May 19, 2000
The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healingA C Berger, A L Feldman, M F Gnant, et al.Pageof 220